NCT05687461进行中（未招募）不适用
Construction of a National Diagnosis and Treatment Quality Control Platform for Major Respiratory Diseases and Technical Promotion of Standardized Diagnosis and Treatment Programs
China-Japan Friendship Hospital1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2022年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10,000
- 试验地点
- 1
- 主要终点
- A respiratory quality control network platform has been established
研究概览
简要总结
- Build a national diagnosis and treatment quality control platform for major respiratory diseases It will establish and improved a "National diagnosis and Treatment quality control Platform for major respiratory diseases", and form a three-level network of diagnosis and treatment quality control for major respiratory diseases with a three-level system structure of "national, provincial and hospital".
- Promote standardized diagnosis and treatment techniques for major respiratory diseases Relying on the specialized disease collaboration group or innovative unit model, all-round and hierarchical precision training and teaching are carried out to popularize and promote standardized diagnosis and treatment technology schemes for major respiratory diseases, so as to achieve the homogenization of diagnosis and treatment level for major respiratory diseases.
详细描述
- Build a national diagnosis and treatment quality control platform for major respiratory diseases Cooperate with the Medical Administration Administration of the National Health Commission, the Medical Administration Institute of the National Health Commission and the National Center for Respiratory Disease Medical Quality Control to integrate the existing diagnosis and treatment quality indicators and data from NCIS (National Medical Quality Management and Control Information Network) and HQMS (Hospital Quality Monitoring System), and determine the definition, data sources and collection rules of core quality control indicators. It has established and improved a "National diagnosis and Treatment quality control Platform for major respiratory diseases", and formed a three-level network of diagnosis and treatment quality control for major respiratory diseases with a three-level system structure of "national, provincial and hospital".
- To master the incidence trend and diagnosis and treatment quality of major respiratory diseases Through the big data integration and analysis function of the "National Diagnosis and Treatment Quality Control Platform for Major Respiratory Diseases", the incidence trend and law of various major respiratory diseases are mastered. To understand the difference in the diagnosis and treatment quality of respiratory diseases in hospitals of different regions and levels, including the allocation of related resources (such as personnel, technology, equipment, information construction, etc.); The status of diagnosis and treatment ability (prevention, diagnosis, treatment, rehabilitation, etc.); Current burden of disease (e.g. morbidity, case fatality rate, average length of stay, average cost of stay, etc.)
- Promote standardized diagnosis and treatment techniques for major respiratory diseases Relying on the specialized disease collaboration group or innovative unit model, through online and offline academic conferences, continuing medical education, specialized training, visits and exchanges, case discussions, knowledge competitions, wechat public accounts and other new media means, regularly focus on "prevention, diagnosis, treatment, rehabilitation, management, quality control" and many other aspects. Comprehensive and hierarchical precision training and teaching should be carried out to popularize and promote standardized diagnosis and treatment technology schemes for major respiratory diseases, so as to achieve the homogenization of diagnosis and treatment levels for major respiratory diseases.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •I. For patients at high risk for VTE 1) Have an expected hospital stay of ≥72 hours for medical and/or surgical treatment II. For patients diagnosed with VTE
- •With clearly diagnosed of deep vein thrombosis or pulmonary thromboembolism
排除标准
- •I. For patients at high risk for VTE
- •VTE identified on CTPA or lower extremity vein ultrasound at or any time before enrollment
- •Requiring a full dose of anticoagulant treatment before enrollment (e.g., recent VTE, atrial fibrillation).
结局指标
主要结局
A respiratory quality control network platform has been established
时间窗: 2025.01
A complete national quality control network platform for the diagnosis and treatment of major respiratory diseases with multi-source data has been built
次要结局
未报告次要终点
研究者
Zhenguo Zhai,MD,PhD
Chief physician
China-Japan Friendship Hospital
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Registry Platform Hematologic Malignancies (RUBIN) - Extension of Tumor Registry Lymphatic NeoplasmsChronic Lymphocytic Leukemia (CLL)Diffuse Large B-cell Lymphoma (DLBCL)Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)Waldenström's Macroglobulinemia (WM)NCT06043011iOMEDICO AG2,950
已完成
不适用
Patient Journey in Hospital With Heart Failure in Turkish PopulationHeart FailureNCT02487056Ege University1,622
尚未招募
1 期
To build a precise diagnosis and treatment system for membranous nephropathy based on the correlation between intestinal microecology and TCM tongue diagnosisITMCTR2000004026onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Unknown
不适用
A Tiered Management System of Osteoporosis in ChinaOsteopeniaOsteoporosisNCT03916289Peking Union Medical College Hospital15,000
Unknown
不适用
Geriatric HIV Cohort in Sub Sahara AfricaNon Communicable DiseasesAgingHIV InfectionsNCT04313699Makerere University500